Dong-A ST Co., Ltd.
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1932-01-01
- Employees
- 1.6K
- Market Cap
- -
- Website
- http://www.donga-st.com
Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2018-02-26
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT02754219
- Locations
- 🇰🇷
Severance Hospital Clinical Trial Center, Seoul, Korea, Republic of
Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-11-10
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 56
- Registration Number
- NCT02725086
- Locations
- 🇰🇷
Severance Hospital, Yonsei University College of Medicine, Seoul, Seodamun-gu, Korea, Republic of
To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers
- First Posted Date
- 2015-10-20
- Last Posted Date
- 2015-10-20
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT02580006
- Locations
- 🇰🇷
Seoul National University Hospital Clinical Trials Center, Seoul, Korea, Republic of
Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers
- First Posted Date
- 2015-09-23
- Last Posted Date
- 2017-04-12
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT02557594
- Locations
- 🇰🇷
Clinical Trial Center, Seoul National University Hospital, Seoul, Korea, Republic of
Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee
- Conditions
- Interventions
- First Posted Date
- 2015-09-18
- Last Posted Date
- 2021-04-14
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 115
- Registration Number
- NCT02554240
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With Monotherapy
- Conditions
- Interventions
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2017-04-12
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 238
- Registration Number
- NCT02433119
- Locations
- 🇰🇷
Gachon University Gil Hospital, Incheon, Korea, Republic of
A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2015-07-22
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT02375139
- Locations
- 🇰🇷
Clinical Trial Center, Seoul National University Hospital, Seoul, Korea, Republic of
Study of Motilitone to Treat Functional Dyspepsia
- First Posted Date
- 2015-02-19
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT02365701
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH
- First Posted Date
- 2014-12-01
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 59
- Registration Number
- NCT02304198
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Gangnam-Gu, Irwon-Dong 50, Korea, Republic of
A Study to Evaluate the Efficacy and Safety of DA-5204
- First Posted Date
- 2014-11-04
- Last Posted Date
- 2014-11-04
- Lead Sponsor
- Dong-A ST Co., Ltd.
- Target Recruit Count
- 434
- Registration Number
- NCT02282670
- Locations
- 🇰🇷
Seoul National Universtiy, Bundang Hospital, IRB, Seongnam, Gyeonggi-do, Korea, Republic of